Pascal Prigent
Chief Executive Officer at GENFIT
Net worth: 110 770 $ as of 31/03/2024
Profile
Pascal Prigent is currently the Chief Executive Officer at Genfit SA. Previously, he held the position of Vice President & General Manager at GlaxoSmithkline SRL from 2011 to 2014, and Vice President-Marketing at GlaxoSmithKline LLC from 2014 to 2017.
Mr. Prigent obtained an MBA from INSEAD in 1995 and an undergraduate degree from NEOMA Business School in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GENFIT SA
0.06% | 01/04/2024 | 30,708 ( 0.06% ) | 110 770 $ | 31/03/2024 |
Pascal Prigent active positions
| Companies | Position | Start |
|---|---|---|
| GENFIT | Chief Executive Officer | 16/09/2019 |
Former positions of Pascal Prigent
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Sales & Marketing | 01/11/2017 |
GlaxoSmithkline SRL
 GlaxoSmithkline SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithkline SRL is a Romanian subsidiary company that operates within the pharmaceutical industry. As a part of the larger GSK Plc, GlaxoSmithkline benefits from the resources and expertise of its parent company. It is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medicines, vaccines, and consumer healthcare products. With a strong focus on innovation and improving global health, GlaxoSmithkline plays a significant role in providing healthcare solutions to people around the world. | Corporate Officer/Principal | 01/03/2014 |
Training of Pascal Prigent
| INSEAD | Masters Business Admin |
| NEOMA Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENFIT | Health Technology |
| Private companies | 2 |
|---|---|
GlaxoSmithkline SRL
GlaxoSmithkline SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithkline SRL is a Romanian subsidiary company that operates within the pharmaceutical industry. As a part of the larger GSK Plc, GlaxoSmithkline benefits from the resources and expertise of its parent company. It is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medicines, vaccines, and consumer healthcare products. With a strong focus on innovation and improving global health, GlaxoSmithkline plays a significant role in providing healthcare solutions to people around the world. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Pascal Prigent
